Partner, Third Rock Ventures
Alexis Borisy is a successful biotechnology entrepreneur with 20 years of experience building and operating innovative science based organizations such as Foundation Medicine, Blueprint Medicines, and CombinatoRx. Alexis is a Partner at Third Rock Ventures, where he focuses on the formation, development and strategy of new companies. He has raised $750 million in financing and business development deals, and has authored numerous scientific papers and patents. Trained in chemistry and chemical biology at Harvard where he was a Howard Hughes Predoctoral Fellow, Alexis was honored as the MIT Technology Review Innovator of the Year.